Physician

Sivamurthy Kyathari, M.D

According to 2025 Medicare claims, Sivamurthy Kyathari, M.D (NPI: 1124171533) practices medical oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (NPI: 1093370918; TIN: 834425637) and primary practice location at 85614-2622.

Kyathari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 739 traditional Medicare patients, billed 123,144 HCPCS/CPT codes, and received $2,094,993 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,203 prescription claims across 247 beneficiaries totaling $2,037,494 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 49 claims. Open Payments data shows 111 records totaling $2,729. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $112,213 to $2,094,993. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $784,777 and ending at $2,037,494. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,013 to $2,553.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	735	2,520	$112,213
2016	631	2,572	$119,373
2017	667	2,395	$113,012
2018	684	2,432	$120,208
2019	621	12,231	$175,189
2020	430	78,486	$817,623
2021	554	82,968	$1,213,049
2022	828	193,257	$2,967,484
2023	784	146,461	$2,498,991
2024	739	123,144	$2,094,993

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	169	910	$784,777
2016	141	854	$779,414
2017	158	970	$1,320,399
2018	219	1,539	$2,263,436
2019	217	1,175	$1,832,941
2020	112	413	$254,086
2021	165	646	$1,160,495
2022	251	1,336	$2,112,881
2023	256	1,350	$2,386,989
2024	247	1,203	$2,037,494

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	50	$3,271
2016	N/R	23	$11,576
2017	N/R	30	$9,584
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	98	$3,723
2023	N/R	49	$2,553
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	115	115	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	520	983	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	93	106	$55
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	61	134	$45
96372	Injection of drug or substance under skin or into muscle	96	223	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	19	532	$314,218
Revlimid	Lenalidomide	23	539	$266,173
Jakafi	Ruxolitinib Phosphate	15	450	$258,687
Ibrance	Palbociclib	12	336	$180,281
Sprycel	Dasatinib	18	600	$145,621

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$2,729	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sivamurthy Kyathari, M.D?

Tedicare shows public-source Medicare data for Sivamurthy Kyathari, M.D (NPI 1124171533), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sivamurthy Kyathari, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sivamurthy Kyathari, M.D?

Sivamurthy Kyathari, M.D is linked to ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (billing NPI 1093370918) in the available physician profile data.

Does Sivamurthy Kyathari, M.D have Open Payments data?

Sivamurthy Kyathari, M.D has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.